← Back to Search

Behavioural Intervention

Personalized Exercise Training for Heart Disease (HRV-Predict Trial)

N/A
Waitlist Available
Led By Louis Bherer, PhD
Research Sponsored by Montreal Heart Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and post-intervention at 3 months
Awards & highlights

HRV-Predict Trial Summary

This trial will compare a personalized exercise program to a standard one to see which works best for cardiovascular rehab.

Who is the study for?
This trial is for adults over 18 with stable angina, acute coronary syndrome, or those who have had a complete coronary revascularization. Participants must be able to do a maximal exercise stress test and sign consent forms. It's not for individuals with recent severe cardiovascular events, heart failure, diabetes, or those who've had bypass grafting.Check my eligibility
What is being tested?
The study compares two types of exercise training in cardiac rehab: one based on daily heart rate variability (HRV) measurements and the other is a standard program without individualized intensity adjustments.See study design
What are the potential side effects?
Exercise programs may cause temporary fatigue, muscle soreness, and in rare cases could trigger underlying heart conditions. However, these are closely monitored to ensure safety.

HRV-Predict Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and post-intervention at 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and post-intervention at 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in cardiorespiratory fitness
Responders and non-responders proportion
Secondary outcome measures
Baroreflex gain
Change in episodic memory
Change in executive functions
+4 more
Other outcome measures
Change in anxiety
Change in depressive symptoms
Change in sleep quality

HRV-Predict Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: HRV-guided exercise trainingExperimental Treatment1 Intervention
The physical exercises intervention will include an individualized aerobic exercises training, three sessions per week for 3 months.
Group II: standard exercise trainingActive Control1 Intervention
The physical exercises intervention will include a standardized aerobic exercises training, three sessions per week for 3 months.

Find a Location

Who is running the clinical trial?

Montreal Heart InstituteLead Sponsor
120 Previous Clinical Trials
68,771 Total Patients Enrolled
21 Trials studying Coronary Artery Disease
13,935 Patients Enrolled for Coronary Artery Disease
Fonds de la Recherche en Santé du QuébecOTHER_GOV
80 Previous Clinical Trials
46,500 Total Patients Enrolled
1 Trials studying Coronary Artery Disease
300 Patients Enrolled for Coronary Artery Disease
Louis Bherer, PhDPrincipal InvestigatorMontreal Heart Institute
8 Previous Clinical Trials
743 Total Patients Enrolled
1 Trials studying Coronary Artery Disease
36 Patients Enrolled for Coronary Artery Disease

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Individualized Exercise Training Based on the Heart Rate Variability in Coronary Heart Disease Patient
Louis Bherer 2021. "Individualized Exercise Training Based on the Heart Rate Variability in Coronary Heart Disease Patient". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04971707.
~13 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top